Resource center

Filter by
Filter by
Show results
Resource type
Key Content Topics
Disease site
Content language
Proton Therapy Publication
June 2023
Analysis of particle therapy registries based on a unified treatment policy for esophageal cancer.
en
Link to the fully detailed content
Proton Therapy Publication
June 2023
Particle beam therapy versus photon radiotherapy for extrahepatic biliary cancer-systemic review and meta-analysis.
en
Link to the fully detailed content
Proton Therapy Publication
May 2023
Acute and long-term toxicity of whole pelvis proton radiation therapy for definitive or adjuvant management of gynecologic cancers.
en
Link to the fully detailed content
Proton Therapy Publication
April 2023
Comparison of local ablative therapies, including radiofrequency ablation, microwave ablation, stereotactic ablative radiotherapy, and particle radiotherapy, for inoperable hepatocellular carcinoma: a systematic review and meta-analysis.
en
Link to the fully detailed content
Proton Therapy Publication
November 2022
A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.
en
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2022
Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade.
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
September 2022
Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
Link to the fully detailed content
Proton Therapy Publication
June 2022
Hematologic Toxicity Comparison of Intensity Modulated Proton Therapy and Intensity Modulated Radiation Therapy in Anal Cancer Patients.
en
Link to the fully detailed content
Proton Therapy Publication
June 2022
Dose-escalated proton therapy with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer: a phase II trial.
en
Link to the fully detailed content
Proton Therapy Publication
Proton therapy publication
June 2022
Dose-escalated PT with elective nodal irradiation and concomitant chemotherapy for unresectable, borderline resectable, or medically inoperable pancreatic cancer
Link to the fully detailed content